Strategies to improve the medical device life cycle in Mexico

Objective. To analyze the role of stakeholders to three alternative strategies to improve processes and practices regarding the regulation, assessment, and management oforthopaedic medical devices in Mexico. Materials and methods. The study was based on document analysis and 17 structured interviews...

Full description

Saved in:
Bibliographic Details
Main Authors: Myriam Lingg (Author), Anahi Dreser (Author), Luis Durán-Arenas (Author), Kaspar Wyss (Author)
Format: Book
Published: Instituto Nacional de Salud Pública, 2018-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_f08f6cf245634c1bab3c53dcf09dbaa0
042 |a dc 
100 1 0 |a Myriam Lingg  |e author 
700 1 0 |a Anahi Dreser  |e author 
700 1 0 |a Luis Durán-Arenas  |e author 
700 1 0 |a Kaspar Wyss  |e author 
245 0 0 |a Strategies to improve the medical device life cycle in Mexico 
260 |b Instituto Nacional de Salud Pública,   |c 2018-06-01T00:00:00Z. 
500 |a 0036-3634 
500 |a 1606-7916 
500 |a 10.21149/9060 
520 |a Objective. To analyze the role of stakeholders to three alternative strategies to improve processes and practices regarding the regulation, assessment, and management oforthopaedic medical devices in Mexico. Materials and methods. The study was based on document analysis and 17 structured interviews with multiple key actors within the Mexican health system to inform a stakeholder analysis aiming at assessing the political feasibility of these strategies. Results. Central level government agencies, those with a relation to quality of care, were identified as most relevant stakeholders to influence the adaption and application of the strategies. Major barriers identified are financial and human resources, and organisational culture towards reform. Conclusion. Discussed strategies are political feasible. However, solving identified barriers is crucial to achieve changes directed to improve outputs and outcomes of medical device life cycle and positively influence the quality of health care and the health system's performance. 
546 |a EN 
546 |a ES 
690 |a health technology 
690 |a regulation 
690 |a assessment 
690 |a management 
690 |a medical device 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Salud Pública de México, Vol 60, Iss 4, jul-ago, Pp 462-471 (2018) 
787 0 |n http://www.saludpublica.mx/index.php/spm/article/view/9060 
787 0 |n https://doaj.org/toc/0036-3634 
787 0 |n https://doaj.org/toc/1606-7916 
856 4 1 |u https://doaj.org/article/f08f6cf245634c1bab3c53dcf09dbaa0  |z Connect to this object online.